Cargando…

Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection

Thrombotic thrombocytopenic purpura (TTP) is a rare and challenging diagnosis that consists of thrombotic microangiopathy due to complete or severe deficiency of ADAMTS13 protease that can present at any age. It is very important to have a suspicion concerning this disease as mortality can be very h...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Krishna, Sridhar, Aarthi, Matos, Jose, Mulla, Sana, Thirumaran, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379868/
https://www.ncbi.nlm.nih.gov/pubmed/35989804
http://dx.doi.org/10.7759/cureus.26933
_version_ 1784768758507634688
author Desai, Krishna
Sridhar, Aarthi
Matos, Jose
Mulla, Sana
Thirumaran, Rajesh
author_facet Desai, Krishna
Sridhar, Aarthi
Matos, Jose
Mulla, Sana
Thirumaran, Rajesh
author_sort Desai, Krishna
collection PubMed
description Thrombotic thrombocytopenic purpura (TTP) is a rare and challenging diagnosis that consists of thrombotic microangiopathy due to complete or severe deficiency of ADAMTS13 protease that can present at any age. It is very important to have a suspicion concerning this disease as mortality can be very high if it goes unnoticed. This case describes a patient that presented with gastrointestinal symptoms and hematuria and was found to have COVID-19 and TTP.  We present a case of a 40-year-old female with no past medical history who presented to the Emergency Department with complaints of abdominal pain, nausea, vomiting, and dark urine. The patient workup revealed a platelet count of 4000. The patient was also noted to be COVID-19 positive. Upon further workup, the TTP diagnosis was confirmed. She responded appropriately to plasmapheresis and steroids. COVID-19 seems to be linked to a wide range of hematologic conditions including but not limited to TTP. In view that TTP can have significant mortality if untreated, we must be suspicious about this condition in COVID-19 cases. The aim of this case report is to highlight the importance of having a low threshold for making a diagnosis of TTP if labs are significant for hemolytic anemia. Our aim is also to emphasize that the treatment should be initiated if schistocytes are seen on the peripheral smear without awaiting laboratory results confirming low levels of ADAMTS13, given the fatal nature of the condition if left untreated.
format Online
Article
Text
id pubmed-9379868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-93798682022-08-18 Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection Desai, Krishna Sridhar, Aarthi Matos, Jose Mulla, Sana Thirumaran, Rajesh Cureus Internal Medicine Thrombotic thrombocytopenic purpura (TTP) is a rare and challenging diagnosis that consists of thrombotic microangiopathy due to complete or severe deficiency of ADAMTS13 protease that can present at any age. It is very important to have a suspicion concerning this disease as mortality can be very high if it goes unnoticed. This case describes a patient that presented with gastrointestinal symptoms and hematuria and was found to have COVID-19 and TTP.  We present a case of a 40-year-old female with no past medical history who presented to the Emergency Department with complaints of abdominal pain, nausea, vomiting, and dark urine. The patient workup revealed a platelet count of 4000. The patient was also noted to be COVID-19 positive. Upon further workup, the TTP diagnosis was confirmed. She responded appropriately to plasmapheresis and steroids. COVID-19 seems to be linked to a wide range of hematologic conditions including but not limited to TTP. In view that TTP can have significant mortality if untreated, we must be suspicious about this condition in COVID-19 cases. The aim of this case report is to highlight the importance of having a low threshold for making a diagnosis of TTP if labs are significant for hemolytic anemia. Our aim is also to emphasize that the treatment should be initiated if schistocytes are seen on the peripheral smear without awaiting laboratory results confirming low levels of ADAMTS13, given the fatal nature of the condition if left untreated. Cureus 2022-07-17 /pmc/articles/PMC9379868/ /pubmed/35989804 http://dx.doi.org/10.7759/cureus.26933 Text en Copyright © 2022, Desai et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Desai, Krishna
Sridhar, Aarthi
Matos, Jose
Mulla, Sana
Thirumaran, Rajesh
Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
title Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
title_full Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
title_fullStr Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
title_full_unstemmed Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
title_short Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
title_sort thrombotic thrombocytopenia masquerading as covid-19 infection
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379868/
https://www.ncbi.nlm.nih.gov/pubmed/35989804
http://dx.doi.org/10.7759/cureus.26933
work_keys_str_mv AT desaikrishna thromboticthrombocytopeniamasqueradingascovid19infection
AT sridharaarthi thromboticthrombocytopeniamasqueradingascovid19infection
AT matosjose thromboticthrombocytopeniamasqueradingascovid19infection
AT mullasana thromboticthrombocytopeniamasqueradingascovid19infection
AT thirumaranrajesh thromboticthrombocytopeniamasqueradingascovid19infection